Efficacy, safety and cost of cefuroxime compared with cephradine in the treatment of acute pyelonephritis during pregnancy

被引:0
|
作者
Ovalle, A [1 ]
Martínez, MA
Wolff, M
Cona, E
Valderrama, O
Villablanca, E
Lobos, L
机构
[1] Hosp San Borja Arriaran, Serv Obstetr Ginecol & Neonatol, Santiago, Chile
[2] Hosp San Borja Arriaran, Unidad Microbiol, Santiago, Chile
[3] Univ Chile, Fac Med, Programa Microbiol, Santiago 7, Chile
关键词
cefuroxime; cephalosporins; cephradine; pregnancy complications; infections; pyelonephritis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Second generation cephalosporins (CFPs) are more active in the treatment of acute pyelonephritis during pregnancy but their cost in considerably higher than their predecessors. Cefuroxime, a second generation CFP with oral and parenteral presentations, might offer significant advantages and become a first choice antimicrobial in this setting. Aim: To compare the efficacy, safety and cost of cefuroxime and cephradine in the treatment of acute pyelonephritis in pregnancy. Patients and methods: Hospitalized women with 12 to 34 weeks of pregnancy, with clinical and bacteriological diagnosis of acute pyelonephritis, were randomly assigned to receive cefuroxime (Curocef (r), Glaxo Wellcome) 750 mg t.i.d, i.v. or cephradine 1 g q.i.d., i.v. If the isolated organism was resistant to the assigned drug the patient was excluded. Once patients were afebrile, they were switched to an oral form of the same antimicrobial. They were discharged according to the clinical status and treated for a total of 14 days. Laboratory tests, including urine culture were requested during controls and at the end of follow-up at 28 days. Results: One hundred and one patients were randomized: 49 to receive cephradine and 52 to receive cefuroxime. Patients in the cefuroxime group had fewer febrile days (mean 1.7 vs 2.2, p<0.05), faster clinical recovery (mean 2.7 vs 3.1 days, p<0.05), a higher rate of bacteriological cure at 28 days (78.8% and 59.2%, p<0.05) and lower rate of failure (21.2% vs 40.8 % p<0.05). The rate of resistance of isolated uropathogens was 14% to cephradine and 1% to cefuroxime. Conclusions: Cefuroxime can be considered as a first choice option in the treatment of acute pyelonephritis during pregnancy due to its tolerance, microbiological activity and efficacy.
引用
收藏
页码:749 / 757
页数:9
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF CEFIXIME IN THE TREATMENT OF ACUTE PYELONEPHRITIS
    WEISSBACH, L
    SEGAL, A
    TROSTER, K
    INFECTION, 1990, 18 : S140 - S144
  • [2] Efficacy and safety of cefuroxime axetil compared to cefpodoxime proxetil in the treatment of acute exacerbations of chronic bronchitis.
    Gaillat, J
    Baranes, C
    Amsellem, D
    Cohen, A
    Bougon, N
    Riebbels, V
    Chauveau, E
    MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 (02): : 52 - 60
  • [3] COMPARATIVE EFFICACY AND TOLERABILITY OF CEPHRADINE AND CEFUROXIME AXETIL IN THE TREATMENT OF ACUTE DYSURIA AND OR FREQUENCY IN GENERAL-PRACTICE
    COOPER, J
    RAEBURN, A
    BRUMFITT, W
    HAMILTONMILLER, JMT
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1992, 46 (01): : 24 - 27
  • [4] Acute pyelonephritis during pregnancy
    Gardner, J
    AMERICAN JOURNAL OF NURSING, 2000, 100 (03) : 24TT - +
  • [5] TREATMENT OF PYELONEPHRITIS DURING PREGNANCY
    KUBLI, F
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1974, 99 (23) : 1274 - 1275
  • [6] EFFICACY OF CEFUROXIME FOR TREATMENT OF ACUTE GONORRHEA IN MEN
    PRICE, JD
    FLUKER, JL
    BRITISH JOURNAL OF VENEREAL DISEASES, 1978, 54 (03): : 165 - 167
  • [7] Increased Proteinuria During Acute Pyelonephritis in Pregnancy
    Chau, Cindy T.
    Fong, Alex
    Simon-Freeman, Rebecca
    Chan, Kenneth K.
    REPRODUCTIVE SCIENCES, 2017, 24 : 125A - 125A
  • [8] Safety and Efficacy of Nicotine Replacement Treatment During Pregnancy
    Garcia-Algar, Oscar
    Jane Checa, Mireia
    ARCHIVOS DE BRONCONEUMOLOGIA, 2010, 46 (09): : 453 - 454
  • [9] EFFICACY AND TOLERANCE OF CEFODIZIME IN THE TREATMENT OF ACUTE PYELONEPHRITIS
    KOURILSKY, O
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 : 111 - 116
  • [10] Safety and efficacy of ureteroscopy after obstructive pyelonephritis treatment
    Kanno, Toru
    Matsuda, Ayumu
    Sakamoto, Hiromasa
    Higashi, Yoshihito
    Yamada, Hitoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (09) : 917 - 922